4//SEC Filing
Lim Bryant David 4
Accession 0001179110-20-000565
CIK 0000861838other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 6:56 PM ET
Size
7.8 KB
Accession
0001179110-20-000565
Insider Transaction Report
Form 4
Lim Bryant David
SVP & General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2020-01-10+50,000→ 50,000 totalExercise: $1.79Exp: 2030-01-10→ Common Stock (50,000 underlying) - Award
Common Stock
2020-01-10+20,000→ 41,240 total
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award granted under the Issuer's 2013 Stock Incentive Plan. Each RSU represents a right to receive one share of Issuer common stock. The RSU award vests over a four-year period commencing on January 10, 2020. Twenty-five percent (25%) of the shares subject to the RSU award shall vest on each one-year anniversary of the grant date of the award.
- [F2]Securities beneficially owned totaling 41,240 includes 7,665 shares of Issuer common stock owned and 33,575 of unvested RSU's held by the reporting person.
- [F3]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 10, 2020. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 10, 2021 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001752888
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 6:56 PM ET
- Size
- 7.8 KB